Renova Therapeutics Company Profile 2024: Valuation, Funding ...

Information on valuation, funding, cap tables, investors, and executives for Renova Therapeutics. Use the PitchBook Platform to explore the full profile.

CouponFollow Extension

$166
OFF

Renova Therapeutics - Company Profile - Tracxn

6 days from now

Nov 5, 2024 · Renova Therapeutics company profile. ... Post money valuation. Revenue multiple. Investors. Jul 23, 2024. $166K. Series C. 6413499. 9697506-Feb 23, 2016. ... Renova …

tracxn.com

$8.49
OFF

Renova Therapeutics Stock Price, Funding, Valuation, Revenue ...

6 days from now

Funding, Valuation & Revenue. 3 Fundings. Renova Therapeutics has raised $8.49M over 3 rounds.. Renova Therapeutics's latest funding round was a Unattributed for $0.17M on …

cbinsights.com

$7.69
OFF

Renova Therapeutics - Raised $7.69M Funding From 2 Investors

6 days from now

Nov 13, 2024 · Their latest funding round was of $166K on Jul 23, 2024 . Renova Therapeutics has raised a total funding of $7.69M over 3 rounds from 2 investors. Investors include NIH and …

tracxn.com

$7
OFF

Renova Therapeutics Company Profile - Office Locations ... - Craft

6 days from now

Renova Therapeutics has 5 employees at their 1 location and $7.5 m in total funding,. See insights on Renova Therapeutics including office locations, competitors, revenue, financials, …

craft.co

FAQs about Renova Therapeutics Company Profile 2024: Valuation, Funding ... Coupon?

What makes Renova Therapeutics unique?

Renova Therapeutics’ investigational gene therapies are based on carefully validated and proprietary insights into disease mechanisms and our founders’ nearly 50 combined years of pioneering work in the gene therapy field. ...

What is Renova Therapeutics rt-100 & RT-200?

CARLSBAD, CA / ACCESSWIRE / May 8, 2024 / Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene therapies on two primary regulatory pathways as key value drivers. ...

Does Renova have an innovation passport?

Renova was awarded an Innovation Passport by the UK's MHRA through the ILAP program for "RT-200 (AAV8.Ucn2) in the treatment of patients with T2DM with Hemoglobin A1c (HbA1c) ≥.8.0% on metformin, and diet and exercise program" (application ILAP/IP/22/56146/02). ...

What is the current valuation of ring Therapeutics?

The current valuation of Ring Therapeutics is 00000. What is Ring Therapeutics’s current revenue? The current revenue for Ring Therapeutics is 000000. How much funding has Ring Therapeutics raised over time? Ring Therapeutics has raised $254M. Who are Ring Therapeutics’s investors? ...

How much money has ring Therapeutics raised?

Ring Therapeutics has raised $254M. Who are Ring Therapeutics’s investors? Alexandria Venture Investments, CJ Investment, Kyowa Kirin, Altitude Life Science Ventures, and Partners Investment are 5 of 9 investors who have invested in Ring Therapeutics. Who are Ring Therapeutics’s competitors? ...